Non-Alcoholic Fatty Liver Disease (Nafld)

Objectives: To assess the incidence of NAFLD and biochemical profile in nondiabeticand diabetic patients. Study Design: It was a cross sectional descriptive study. Setting:Shalamar Institute of Health Sciences (SIHS), Lahore. Period: Six months, Jan 2015 to Jun2015. Methods: The patients coming to the Radiology Department for abdominal ultrasoundwere age and sex matched into fatty liver and non-fatty liver groups and diabetic and nondiabeticgroups and were further evaluated on the basis of glucose, alanine aminotransferase(ALT) and triglycerides (TG) levels from the laboratory data. Results: The findings of allbiochemical parameters were raised in diabetic patients with fatty liver as well as in non-fattyliver diabetic group and the differences were found to be statistically (P value less than 0.05)significant. In non-diabetic group, out of 200 subjects 56.5% had NAFLD whereas 43.5% hadno NAFLD. In diabetic patients, out of 200 patients 69% had NAFLD and 31% had no NAFLDand the difference was significant statistically (P= <0.05). The prevalence of NAFLD 12.5%was higher in type-2 diabetic patients as compared to non-diabetic group. In non-diabeticgroup, 113 subjects had TG value of 181±82.49, while 87 subjects had TG of 141±44.5. Indiabetic patients, 138 patients had TG value of 467±277.64 whereas 62 patients had TG valueof 178±46.52, which was statistically significant (P= <0.05). Conclusion: Fatty liver is animportant marker for metabolic syndrome which is a pre-diabetic condition. The occurrenceof NAFLD was elevated in type II patients of diabetes. The traditional risk factors for NAFLDare considered to be female sex, type II diabetes mellitus, obesity and hypertriglyceridemia.Hyperglycemia, hypertriglyceridemia and elevated ALT were observed more repeatedly in fattyliver than in non-fatty liver (type II) diabetic patients